SCHEMBL18333369

SCHEMBL18333369

O=C([C@H]1CCCO1)N1CCC(Cc2ccc(-c3cnc4ccccc4c3)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 1/20 0.52
▸ FASN P49327 5/20 0.48
▸ CCR3 P51677 1/20 0.48
▸ KDM4E B2RXH2 3/20 0.45
▸ HTT P42858 1/20 0.45
▸ ALDH1A1 P00352 5/20 0.44
▸ PKM P14618 1/20 0.44
▸ TSHR P16473 2/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ PARP1 P09874 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ ALOX12 P18054 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21651719 1.00 FAAH (0.52) FAAHFASNCCR3KDM4EHTT
SCHEMBL18321593 0.87 FASN (0.43) FAAHFASNKDM4EHTTALDH1A1
SCHEMBL18321594 0.87 FASN (0.43) FAAHFASNKDM4EHTTALDH1A1
SCHEMBL18321590 0.87 FASN (0.43) FAAHFASNKDM4EHTTALDH1A1
SCHEMBL18321742 0.85 FASN (0.59) FAAHFASNCCR3ALDH1A1SMN1; SMN2
SCHEMBL18321711 0.84 FASN (0.47) FAAHFASNKDM4EHTTALDH1A1
SCHEMBL18321692 0.84 FASN (0.54) FASNKDM4EHTTALDH1A1PKM
SCHEMBL18321712 0.84 FASN (0.47) FAAHFASNKDM4EHTTALDH1A1
SCHEMBL18321690 0.84 FASN (0.54) FASNKDM4EHTTALDH1A1PKM
SCHEMBL18321509 0.84 ALDH1A1 (0.46) FASNKDM4EHTTALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919875-B2 Substituted 4-benzyl and 4-benzoyl piperidine derivatives 89BIO LTD (IL) 2021-02-16 — — US disclosed
EP-3310773-B1 SUBSTITUTED 4-BENZYL AND 4-BENZOYL PIPERIDINE DERIVATIVES 89BIO LTD (IL) 2020-12-02 — — EP disclosed
US-20200031797-A1 SUBSTITUTED 4-BENZYL AND 4-BENZOYL PIPERIDINE DERIVATIVES CEPHALON LLC 2020-01-30 — — US disclosed
WO-2016205590-A1 SUBSTITUTED 4-BENZYL AND 4-BENZOYL PIPERIDINE DERIVATIVES CEPHALON, INC. (US) 2016-12-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200031797-A1 SUBSTITUTED 4-BENZYL AND 4-BENZOYL PIPERIDINE DERIVATIVES FASN, FADS1, ASS1 FAAH 160/4885FASN 1/4885CCR3 4562/4885
US-10919875-B2 Substituted 4-benzyl and 4-benzoyl piperidine derivatives FASN, CES1, FADS2 FAAH 87/4885FASN 1/4885CCR3 4531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback